Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 5,430.00
-170.00 (-3.04%)
Apr 30, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 246.95 billion as of April 30, 2026. Its market cap has increased by 43.27% in one year.
Market Cap
246.95B
Enterprise Value
n/a
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,430.00
Market Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 246.95B, an increase of 126.52%. That is a compound annual growth rate of 5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 254.69B | 19.53% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 372.23B |
| BINEX | 368.48B |
| GC Cell | 368.16B |
| HLB Therapeutics | 323.97B |
| Bioneer | 281.33B |
| EASY BIO,Inc. | 261.68B |
| JETEMA, | 260.84B |
| MedPacto | 188.17B |